A homozygous UBA5 pathogenic variant causes a fatal congenital neuropathy

Abstract

BackgroundUBA5 is the activating enzyme of UFM1 in the ufmylation post-translational modification system. Different neurological phenotypes have been associated with UBA5 pathogenic variants including epilepsy, intellectual disability, movement disorders and...